BERKELEY'S NEWS • OCTOBER 01, 2022

tag

Cas9

Page 1 of 1

UC Berkeley announced Tuesday that the U.S. Patent and Trademark Office has granted a patent to CRISPR, a gene-editing technology.
featured article
UC Berkeley announced Tuesday that the U.S. Patent and Trademark Office has granted a patent to CRISPR, a gene-editing technology.
featured article
The patent is based on the enzyme system CRISPR-Cas9, which was discovered in 2012 by Jennifer Doudna and Emmanuelle Charpentier.
featured article
The patent is based on the enzyme system CRISPR-Cas9, which was discovered in 2012 by Jennifer Doudna and Emmanuelle Charpentier.
featured article
Scientists have engineered a new, more accurate protein for CRISPR-Cas9 gene editing called HypaCas9, which cuts at target sites with higher accuracy and reduces the chances of unintentional externalities.
featured article
Scientists have engineered a new, more accurate protein for CRISPR-Cas9 gene editing called HypaCas9, which cuts at target sites with higher accuracy and reduces the chances of unintentional externalities.
featured article
Researchers at UC Berkeley and UC Riverside have merged computational and molecular biology to demonstrate the potential that gene modification may have in suppressing mosquito-borne infectious diseases.
featured article
Researchers at UC Berkeley and UC Riverside have merged computational and molecular biology to demonstrate the potential that gene modification may have in suppressing mosquito-borne infectious diseases.
featured article
Researchers at UC Berkley and UCSF published new findings about gene-modifying proteins in December connected to their research of CRISPR technology, a natural bacterial defense mechanism that is the subject of an ongoing patent dispute.
featured article
Researchers at UC Berkley and UCSF published new findings about gene-modifying proteins in December connected to their research of CRISPR technology, a natural bacterial defense mechanism that is the subject of an ongoing patent dispute.
featured article
Two UC Berkeley scientists received Tang Prizes in the categories of biopharmaceutical science and sustainable development over the weekend that grant them funds for research as well as a $1.24 million cash prize.
Two UC Berkeley scientists received Tang Prizes in the categories of biopharmaceutical science and sustainable development over the weekend that grant them funds for research as well as a $1.24 million cash prize.
Building on groundbreaking research in gene therapy released by UC Berkeley scientists, Bay Area researchers will work to push the boundaries of genetic engineering in a new collaboration between UC Berkeley and UC San Francisco.
Building on groundbreaking research in gene therapy released by UC Berkeley scientists, Bay Area researchers will work to push the boundaries of genetic engineering in a new collaboration between UC Berkeley and UC San Francisco.